President Trump was uncharacteristically modest in endorsing a series of pricing proposals put forth by HHS Secretary Azar, and that may turn out to be a good thing for the future of biomedical innovation.
from Forbes Real Time https://www.forbes.com/sites/johnosborn/2018/05/12/trumps-drug-pricing-reform-proposals-may-be-politically-tepid-but-are-eminently-sensible/
via IFTTT
No comments:
Post a Comment